2 nm. These results also implied the potential of the present strategy for more separations at a molecular level and very fine nanoscale.The strain modulation on the magnetic and electronic transport properties of the ferromagnetic films is one of the hot topics due to the practical applications in flexible and wearable spintronic devices.  https://www.selleckchem.com/products/caspofungin-acetate.html  However, the large strain-induced saturation magnetization and resistance change is not easy to achieve because most of the ferromagnetic films deposited on flexible substrates are polycrystalline or amorphous. Here, the flexible epitaxial γ'-Fe4N/mica films are fabricated by facing-target reactive sputtering. At a tensile strain with a radius of curvature (ROC) of 3 mm, the saturation magnetization (Ms) of the γ'-Fe4N/mica film is tailored significantly with a maximal variation of 210%. Meanwhile, the magnetic anisotropy was broadly tunable at different strains, where the out-of-plane Mr/Ms at a tensile strain of ROC = 2 mm is six times larger than that at the unbent state. Besides, the strain-tailored longitudinal resistance Rxx and anomalous Hall resistivity ρxy appear where the drop of Rxx (ρxy) reaches 5% (22%) at a tensile strain of ROC = 3 mm. The shift of the nitrogen position in the γ'-Fe4N unit cell at different bending strains plays a key role in the strain-tailored magnetic and electronic transport properties. The flexible epitaxial γ'-Fe4N films have the potential applications in magneto- and electromechanical wearable spintronic devices.A convergent total synthesis of lamellarins S and Z is described. The synthesis features a halogen dance of an easily accessible α,β-dibromopyrrole promoted by an ester moiety. The resultant β,β'-dibromopyrrole undergoes a ligand-controlled Suzuki-Miyaura coupling to provide a range of diarylated pyrrole derivatives. The established synthetic method was also applicable to the synthesis of ningalin B and lukianols A and B.Metal-ligand coordination interactions are usually much stronger than weak intermolecular interactions. Nevertheless, here, we show experimental evidence and theoretical confirmation of a very rare example where metal-ligand bonds dissociate in an irreversible way, helped by a large number of weak intermolecular interactions that surpass the energy of the metal-ligand bond. Thus, we describe the design and synthesis of trinuclear Mn2Fe complex [Mn(L)(H2O)]2Fe(CN)6,2- starting from a mononuclear Mn(III)-Schiff base complex [Mn(L)(H2O)Cl] (1) and [Fe(CN)6]4- anions. This reaction implies the dissociation of Mn(III)-Cl coordination bonds and the formation of Mn(III)-NC bonds with the help of several intermolecular interactions. Here, we present the synthesis, crystal structure, and magnetic characterization of the monomeric Mn(III) complex [Mn(L)(H2O)Cl] (1) and of compound (H3O)[Mn(L)(H2O)2][Mn(L)(H2O)]2Fe(CN)6·4H2O (2) (H2L = 2,2'-((1E,1'E)-(ethane-1,2-diylbis(azaneylylidene))bis(methaneylylidene))bis(4-methat the bond dissociation energy (-29.3 kcal/mol) for the Mn(III)-Cl bond is smaller than the summation of all the weak intermolecular interactions (-30.1 kcal/mol). Variable-temperature magnetic studies imply the existence of weak intermolecular antiferromagnetic couplings in both compounds, which can be can cancelled with a critical field of ca. 2.0 and 2.5 T at 2 K for compounds 1 and 2, respectively. The magnetic properties of compound 1 have been fit with a simple S = 2 monomer with g = 1.959, a weak zero-field splitting (|D| = 1.23 cm-1), and a very weak intermolecular interaction (zJ = -0.03 cm-1). For compound 2, we have used a model with an S = 2 monomer with ZFS plus an S = 2 antiferromagnetically coupled dimer with g = 2.009, |D| = 1.21 cm-1, and J = -0.42 cm-1. The metamagnetic behavior of both compounds is attributed to the weak intermolecular π-π and hydrogen-bonding interactions.The strength of hydrogen bonding to and structure of hydrated oxometallate ions in aqueous solution have been studied by double difference infrared (DDIR) spectroscopy and large-angle X-ray scattering (LAXS), respectively. Anions are hydrated by accepting hydrogen bonds from the hydrating water molecules. The oxygen atom of the permanganate and perrhenate ions form weaker and longer hydrogen bonds to water than the hydrogen bonds in bulk water (i.e., they act as structure breakers), while the oxygen atoms of the chromate, dichromate, molybdate, tungstate, and hydrogenvanadate ions form hydrogen bonds stronger than those in bulk water (i.e., they act as structure makers). The oxometallate ions form one hydration shell distinguishable from bulk water as determined by DDIR spectroscopy and LAXS. The hydration of oxoanions results in X-O bond distances ca. 0.02 Å longer than those in unsolvated ions in the solid state not involved in strong bonding to counterions. The oxygens of oxoanions with a central atom from the second and third series in the periodic table and the hydrogenvanadate ion hydrogen bind three hydrating water molecules, while oxygens of oxoanions with a heavier central atom only form hydrogen bonds to two water molecules.The recent disclosure of type I 1/2 inhibitors for p38α MAPK demonstrated how the stabilization of the R-spine can be used as a strategy to greatly increase the target residence time (TRT) of inhibitors. Herein, for the first time, we describe N-acylhydrazone and selenophene residues as spine motifs, yielding metabolically stable inhibitors with high potency on enzymatic, NanoBRET, and whole blood assays, improved metabolic stability, and prolonged TRT.An experimental approach is described for late-stage lead diversification of frontrunner drug candidates using nanomole-scale amounts of lead compounds for structure-activity relationship development. The process utilizes C-H bond activation methods to explore chemical space by transforming candidates into newly functionalized leads. A key to success is the utilization of microcryoprobe nuclear magnetic resonance (NMR) spectroscopy, which permits the use of low amounts of lead compounds (1-5 μmol). The approach delivers multiple analogues from a single lead at nanomole-scale amounts as DMSO-d6 stock solutions with a known structure and concentration for in vitro pharmacology and absorption, distribution, metabolism, and excretion testing. To demonstrate the feasibility of this approach, we have used the antihistamine agent loratadine (1). Twenty-six analogues of loratadine were isolated and fully characterized by NMR. Informative SAR analogues were identified, which display potent affinity for the human histamine H1 receptor and improved metabolic stability.